Tetracycline-containing chitosan microspheres for local treatment of Helicobacter pylori infection

Cellulose

Volumn 14, Issue 1, 2007, Pages 3-14

  Amiji, Mansoor M ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Chitosan microspheres; Helicobacter pylori; Localized therapy; Mongolian gerbil model; Tetracycline

Indexed keywords

BIOCHEMISTRY; DISEASES; DRUG THERAPY; MICROSPHERES;

CHITOSAN MICROSPHERES; HELICOBACTER PYLORI INFECTION; LOCALIZED THERAPY; MONGOLIAN GERBIL MODEL; TETRACYCLINE;

CHITIN;

CHITOSAN; DISEASE; DISEASE MANAGEMENT; DRUG DELIVERY;

EID: 33947669907     PISSN: 09690239     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10570-006-9070-3     Document Type: Article

References (52)

1. Bell G.D., Powell K., Burridge S.M., Pallecaros A., Jones P.H., Gant P.W., Harrison G., Trowell J.E. (1992). Experience with "triple" anti Helicobacter pylori eradication therapy: Side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment. Pharmacol. Ther. 6:427-435
2. Bingel S.A. (1995). Pathologic findings in an aging Mongolian gerbil (Meriones unguiculatus) colony. Lab. Anim. Sci. 45:597-600
3. Blaser M.J. (1987). Gastric Campylobacter-like organisms, gastritis and peptic ulcer disease. Gastroenterology 93:371-383
4. Blaser M.J. (1990). Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J. Infect. Dis. 161:626-633
5. Chandy T., Sharma C.P. (1990). Chitosan - as a biomaterial. Biomat. Art. Cells. Art. Org. 18:1-24
6. Claesson P.M., Ninham B.W. (1992). pH-dependent interactions between adsorbed chitosan layers. Langmuir 8:1406-1412
7. Domard A., Cartier N. (1992). Glucosamine oligomers: IV. Solid state-crystallization and sustained dissolution. Int. J. Biol. Macromol. 14:100-106
8. Dore M.P., Sepulveda A.R., Mura I., Realdi G., Osato M.S., Graham D.Y. (1997). Explanation for variability of omeprazole amoxicillin therapy? Tolerance of H. pylori to amoxicillin. Gastroenterology 112:A105
9. Eaton K.A., Morgan D.R., Krakowka S. (1994). Campylobacter pylori virulence factors in gnotobiotic piglets. Infect. Immun. 57:1119-1125
10. Forman D., Newell D.G., Fullerton F., Yarnell J.W., Stacey A.R., Wald N., Sitas F. (1991). Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. Br. Med. J. 302:1302-1305
11. H. pylori and peptic ulcer disease. 2003. URL http://www.cdc.gov/ulcer/ md.htm#fda. (10/10/2003)
12. Hazell S.L., Lee A., Brady L. (1986). Campylobacter pyloridis and gastritis: Association with intracellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J. Infect. Dis. 153:658-663
13. Hejazi R. and Amiji M. 2001. Chitosan-based delivery systems: physicochemical properties and pharmaceutical applications. In: Dumitriu S. (ed.), Polymeric Biomaterials. Second Edition, Revised and Expanded. Marcel Dekker, Inc., New York, NY, Chapter 10, pp. 213-238
14. Hejazi R., Amiji M. (2002). Stomach-specific anti- H. pylori therapy. I: preparation and characterization of tetracycline-loaded chitosan microspheres. Int. J. Pharm. 235(1-2):87-94
15. Hejazi R., Amiji M. (2003a). Chitosan-based gastrointestinal delivery systems. J. Control. Release 89:151-165
16. Hejazi R., Amiji M. (2003b). Stomach-specific anti- H. pylori therapy. II: Gastric residence studies of tetracycline-loaded chitosan microspheres in gerbils. Pharm. Dev. Technol. 8:253-262
17. Hejazi R., Amiji M. (2004). Stomach-specific anti- H. pylori therapy. III: Effect of chitosan microsphere crosslinking on the gastric residence and local tetracycline concentrations in fasted gerbils. Int. J. Pharm. 272(1-2):99-108
18. Hirano S., Seino H., Akiyama Y., Nonaka I. (1990). Chitosan: A biocompatible material for oral and intravenous administrations. In: Gebelein C.G., Dunn R.L. (eds), Progress in Biomedical Polymers. Plenum Press, New York NY, pp. 283-290
19. Hoppe-Seiler F. (1994). Chitin and chitosan. Ber. Deutsch Chem. Ges. 27:3329-3331
20. Hunt R.H. (1995). Helicobacter pylori eradication: A critical appraisal and current concerns. Scand. J. Gastroenterol. 30:73-76
21. Ikeno T., Ota H., Sugiyama A., Ishida K., Katsuyama T., Genta R.M., Kawasaki S. (1999). Helicobacter pylori-induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils. Am. J. Pathol. 154:951-960
22. Ito M., Ban A., Ishihara M. (2000). Anti-ulcer effects of chitin and chitosan, healthy foods, in rats. Jpn. J. Pharmacol. 82:218-225
23. Knapczk J., Krowczynski L., Pawlik B., Liber Z. (1984). Pharmaceutical dosage forms with chitosan. In: Skjak-Braek G., Anthonsen T., Sandford P. (eds), Chitin and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties and Applications. Elsevier Applied Science, London, UK, pp. 665-669
24. Lee A. (1999). Animal models of Helicobacter infection. Mol. Med. Today 5:500-501
25. Lehr C.M., Bouwstra J.A., Schacht E., Junginger H.E. (1992). In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78:43-48
26. Levy S.B. (1992). The Antibiotic Paradox: How Miracle Drugs are Destroying the Miracle. Plenum Press Inc., New York, NY
27. Malfertheiner P. (1993). Compliance, adverse events, and antibiotic resistance in Helicobacter pylori treatment. Scand. J. Gastroenterol. 28:34-37
28. Marshall B.J. (1983). Unidentified curved bacilli in gastric epithelium in active chronic gastritis. Lancet 1:1273-1275
29. Marshall B.J., Warren J.R. (1984). Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311-1315
30. Matsumoto S., Washizuka Y., Matsumoto Y., Tawara S., Ikeda F., Yokota Y., Karita M. (1997). Induction of ulceration and severe gastritis in Mongolian gerbil by Helicobacter pylori infection. J. Med. Microbiol. 46:391-397
31. Megraud F. 1994. Helicobacter pylori resistance to antibiotics. In: Hunt R.H. and Tytgat Guido N.J. (eds), Helicobacter pylori: Basic Mechanisms to Clinical Cure. Kluwer Academic Publishers, Dordrecht, The Netherlands, pp. 570-583
32. Mergaud F., Trimoulet P., Lamouliatte H., Boyanova L. (1991). Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells. Antimicrob. Agents Chemother. 35:869-872
33. Miyazaki S., Nakayama A., Oda M., Takada M., Attwood D. (1994). Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. Biol. Pharm. Bull. 17:745-747
34. NIH Consensus Conference (1994). Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 272:65-69
35. Nomura A.M., Stemmermann G.N., Chyou P.H., Kato I., Perez-Perez G.I., Blaser M.J. (1991). Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 325:1132-1136
36. Parsonnet J., Friedman G.D., Vandersteen D.P., Chang Y., Vogelman J.H., Orentreich N., Sibley R.K. (1991). Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325:1127-1131
37. Patel V.R., Amiji M.M. (1996a). pH-sensitive swelling and drug release properties of chitosan-poly(ethylene oxide) semi-interpenetrating polymer network. In: Ottenbrite R., Huang S., Park K. (eds), Hydrogels and Biodegradable Polymers for Bioapplications Volume 627. American Chemical Society Syposium Publication, Washington, DC, pp. 209-220
38. Patel V.R., Amiji M.M. (1996b). Preparation and characterization of freeze-dried chitosan-poly(ethylene oxide) hydrogels for site-specific antibiotic delivery in the stomach. Pharm. Res. 13:588-593
39. Patel V.R., Amiji M.M. (1996c). pH-sensitive swelling and drug release properties of chitosan-poly(ethylene oxide) semi-interpenetrating polymer network. In: Ottenbrite R., Huang S., Park K. (eds), Hydrogels and Biodegradable Polymers for Bioapplications Volume 627. American Chemical Society Symposium Series Publication. American Chemical Society, Washington, DC, pp 209-220
40. Peterson W.L., Graham D.Y., Marshall B., Blaser M.J., Genta R.M., Klein P.D., Stratton C.W., Drnec J., Prokocimer P., Siepman N. (1993). Clarithromycin as monotherapy for eradication of Helicobacter pylori: A randomized, double-blind trial. Am. J. Gastroenterol. 88:1860-1864
41. Qaqish R.B., Amiji M.M. (1999). Synthesis of fluorescent chitosan derivative and its application for the study of chitosan-mucin interactions. Carbohyd. Polym. 38:99-107
42. Reddy R., Osato M., Gutierrez O., Kim J.G., Graham D.Y. (1996). Metronidazole resistance is high in Korea and Columbia and appears to be rapidly increasing in the US. Gastroenterology 10:A236
43. Rha C.K., Rodriguez-Sanchez D., Kienzle-Sterzer C. (1984). Novel applications of chitosan. In: Colwell R.R., Pariser E.R., Sinskey A.J. (eds), Biotechnology of Marine Polysaccharides. Hemisphere Publishing, Washington, DC, pp. 284-311
44. Roberts G.A.F. (1992). Solubility and solution behaviour of chitin and chitosan. In: Roberts G.A.F. (ed.), Chitin Chemistry. MacMillan Press, Houndmills, pp. 274-329
45. Roberts G.A.F. (1992). Structure of chitin and chitosan. In: Roberts G.A.F. (ed.), Chitin Chemistry. MacMillan Press, Houndmills, pp. 1-53
46. Talley N.J., Zinsmeister A.R., Weaver A., DiMagno E.P., Carpenter H.A., Perez-Perez G.I., Blaser M.J. (1991). Gastric adenocarcinoma and Helicobacter pylori infection. J. Natl. Cancer Inst. 83:1734-1739
47. The United States Pharmacopeia/National Formulary. 1990. Volume XXII. The United States Pharmacopeial Convention, Inc. Rockville, MD, 1788
48. Tytgat G.N.J., Noach L., Rauws E.A.J. (1991). Helicobacter pylori. Scand. J. Gastroenterol. 26:1-8
49. Vasquez A., Valdez Y., Gilman R.H., McDonald J.J., Westblom T.U., Berg D., Mayta H., Gutierrez V. (1996). Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format. J. Clin. Microbiol. 34:1232-1234
50. Worthington J.M., Fulghum R.S. (1988). Cecal and fecal bacterial flora of the Mongolian gerbil and the chinchilla. Appl. Environ. Microbiol. 54:1210-1215
51. Yalpana M., Pantaleone D. (1994). An examination of the unusual susceptibilities of aminoglycans to enzymatic hydrolysis. Carbohyd. Res. 256:159-175
52. Yao K.D., Peng T. (1994). Swelling kinetics and release characteristics of crosslinked chitosan: Polyether polymer network (semi-IPN) hydrogels. J. Polym. Sci., Part A: Polym. Chem. 32:1213-1223